A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis.

Trial Profile

A Phase 1b, Exploratory Study to Assess the Safety, Tolerability, Colonic Tissue Exposure, and Anti-Inflammatory Effects of Two Different Doses of SRT2104 in Subjects With Mild to Moderate Ulcerative Colitis.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs SRT 2104 (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Sirtris
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Feb 2012 Actual initiation date (Feb 2012) added as reported by ClinicalTrials.gov.
    • 24 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top